Heirani-Tabasi Asieh, Toosi Shirin, Mirahmadi Mahdi, Mishan Mohammad Amir, Bidkhori Hamid Reza, Bahrami Ahmad Reza, Behravan Javad, Naderi-Meshkin Hojjat
Department of stem Cells and Regenerative Medicine Research, ACECR-Khorasan Razavi Branch Institute, Mashhad, 917751436 Iran.
2Department of Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, 917751436 Iran.
Tissue Eng Regen Med. 2017 Sep 19;14(5):605-615. doi: 10.1007/s13770-017-0069-7. eCollection 2017 Oct.
MSC-based therapy is providing a cure for degenerative diseases with unmet medical need and usually iliac crest bone marrow (ICBM) are being applied in clinics. Alternative sources, including adipose tissue and reamer/irrigator/aspirator hold great potential for isolating MCSs. Here, we compared original MSCs features of adipose tissue (Ad-MSCs) and bone marrow of long-bone (RIA-MSCs) or iliac crest, and the expression of chemokine receptors (including , , , , and ) in these three sources, which are important in the context of homing. We further investigated the role of SDF-1/CXCR4 axis as a key player in motility of different population of MSCs using Transwell migration assay. All cells exhibited typical MSCs characteristics. However, different MSCs sources expressed different levels of chemokine receptors. Generally, the expression of these chemokine receptors was decreased with increasing passage (P) number from 2 to 3. Interestingly, it was observed that the expression and migration capacity in Ad-MSCs is significantly higher than ICBM and RIA-MSCs in P2. Although our data showed that CXCR4 had highest expression in P2 Ad-MSCs, but it dramatically declined following sub-culturing in the P3. Hence, to improve homing of MSCs by means of chemokine/their receptors axis, the source of isolation and passage number should be considered for clinical applications.
基于间充质干细胞(MSC)的疗法正在为满足未被满足的医疗需求的退行性疾病提供治疗方法,临床上通常应用髂嵴骨髓(ICBM)。包括脂肪组织以及骨钻/冲洗器/吸引器在内的其他来源在分离MSC方面具有巨大潜力。在此,我们比较了脂肪组织来源的原始MSC(Ad-MSC)以及长骨骨髓(RIA-MSC)或髂嵴骨髓的特征,以及这三种来源中趋化因子受体(包括 、 、 、 、 和 )的表达,这些趋化因子受体在归巢过程中具有重要作用。我们进一步使用Transwell迁移试验研究了SDF-1/CXCR4轴作为不同群体MSC迁移关键因素的作用。所有细胞均表现出典型的MSC特征。然而,不同的MSC来源表达不同水平的趋化因子受体。一般来说,随着传代次数从第2代增加到第3代,这些趋化因子受体的表达会降低。有趣的是,观察到在第2代时,Ad-MSC中的 表达和迁移能力显著高于ICBM和RIA-MSC。尽管我们的数据显示CXCR4在第2代Ad-MSC中表达最高,但在第3代继代培养后其表达急剧下降。因此,为了通过趋化因子/其受体轴改善MSC的归巢,在临床应用中应考虑分离来源和传代次数。